Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H8BrO4.Na |
| Molecular Weight | 307.073 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].COC1=CC=C(C=C1)C(=O)C(\Br)=C/C([O-])=O
InChI
InChIKey=DVDCIQWIGOVWEX-MLBSPLJJSA-M
InChI=1S/C11H9BrO4.Na/c1-16-8-4-2-7(3-5-8)11(15)9(12)6-10(13)14;/h2-6H,1H3,(H,13,14);/q;+1/p-1/b9-6+;
| Molecular Formula | C11H8BrO4 |
| Molecular Weight | 284.083 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Bromebric Acid (Cytembena) is a derivative of bromoacrylic acid with cytostatic and antineoplastic activity. Chemical structure of Bromebric Acid is not related to any previous antineoplastic agent. In animal tumor screens, Jelinek and Semonsky noted antineoplastic activity of Cytembena against sarcoma 180, atlenocarcinoina of the lactic gland in mice, Ehrlich’s ascitic carcinoma, Yoshida’s ascitic sarcoma, and Zojdeln’s heap
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:39:38 GMT 2025
by
admin
on
Mon Mar 31 22:39:38 GMT 2025
|
| Record UNII |
9V238C7BMX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C272
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
21739-91-3
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
PRIMARY | |||
|
9V238C7BMX
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
PRIMARY | |||
|
DTXSID5020368
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
PRIMARY | |||
|
23665583
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
PRIMARY | |||
|
100000092633
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
PRIMARY | |||
|
C1360
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
PRIMARY | NCIT | ||
|
4134
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
PRIMARY | |||
|
16170-75-5
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
104801
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
PRIMARY | |||
|
SUB26045
Created by
admin on Mon Mar 31 22:39:38 GMT 2025 , Edited by admin on Mon Mar 31 22:39:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |